GRAIL, Inc.
GRAL•NASDAQ•Healthcare•Diagnostics & Research

About GRAIL

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitegrail.com
Phone833 694 2553
Address
1525 O’Brien Drive Menlo Park, California 94025 United States

Corporate Identifiers

CIK0001699031
CUSIP384747101
ISINUS3847471014
EIN86-3673636
SIC8071

Leadership Team & Key Executives

Robert P. Ragusa
Chief Executive Officer and Director
Dr. Joshua J. Ofman M.D., M.S.H.S
President
Aaron Freidin
Chief Financial Officer
Paul Ciccolella
Senior Vice President of Global Development and Operations
Sir Harpal S. Kumar M.A., M.B.A., MEng
Chief Scientific Officer and President International
Abram Barth J.D., M.P.H.
General Counsel and Corporate Secretary
Alexis Tosti
Vice President of Strategy and Corporate Development
Alison Highlander
Senior Vice President of Human Resources and Head of People Team
Dr. Satnam Alag Ph.D.
Senior Vice President of Software Engineering and Chief Security Officer
Andrew John Partridge
Chief Commercial Officer